NCT00439283 Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis Status COMPLETED Phase PHASE3
NCT00434044 Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing Spondylitis Status COMPLETED Phase PHASE3
NCT00432653 Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis Status UNKNOWN Phase PHASE2/PHASE3
NCT00421980 An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis Status COMPLETED Phase PHASE3
NCT00421915 Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis Status COMPLETED Phase PHASE3
NCT00420238 Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing Spondylitis Status COMPLETED Phase PHASE4
NCT00418548 Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis Status COMPLETED Phase PHASE3
NCT00410046 Extension Study Evaluating Etanercept in Ankylosing Spondylitis Status COMPLETED Phase PHASE4
NCT00367211 Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers. Status COMPLETED Phase PHASE3
NCT00273858 Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis Status TERMINATED Phase N/A
NCT00247962 Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis Status COMPLETED Phase PHASE4
NCT00237419 Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis Status UNKNOWN Phase NA
NCT00227227 Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis Status COMPLETED Phase N/A
NCT00224562 The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists Status UNKNOWN Phase N/A